Drug Development and Drug Interactions | Resources
Possible models for decision making, advisory committee meetings, presentations, preventable adverse reactions
Drug Development and Drug Interactions: Advisory Committee Meetings
Drug Development and Drug Interactions: Advisory Committee Meetings
Drug Interaction Presentations
Drug Interaction Presentations
UPDATED PUBLIC PARTICIPATION INFORMATION: January 10, 2025: Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement – 01/10/2025
January 10, 2025: Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement
FDA Clinical Investigator Training Course (CITC) 2024 – 12/10/2024
FDA Clinical Investigator Training Course (CITC) 2024
Verified Clinical Benefit | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications with postmarketing trials that have verified clinical benefit…
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines…
Analytical and behavioral characterization of 1‐dodecanoyl‐LSD (1DD‐LSD)
The development of novel lysergamides provides new opportunities for extending the understanding of their structure–activity relationships. At the same time,…
Performance‐enhancing substances in sport: A scientometric review of 75 years of research
The use of performance-enhancing substances in sports undermines values and risks athletes’ health. This study analyzes doping literature, identifying influential…
Alternative routine for reporting chiral amphetamine test results in assessment of attention‐deficit/hyperactivity disorder medication: experiences from 2013 to 2023
The study describes experiences with a new routine for reporting chiral amphetamine test results that is adapted to the currently…